ACUS

Healthcare Drug Manufacturers - Specialty & Generic

Acusphere, Inc.

$0.00

-0.00 -0.00% today

Price History

Not enough data

Key Stats

Market Cap

3.71M

Avg Volume

52W High

$0.00

52W Low

$0.00

Div. Yield

0.0%

Valuation

P/B Ratio

-0.00

P/S Ratio

1.38

EV/EBITDA

-0.21

EV/Revenue

2.53

PEG Ratio

1.17

Margins

Gross Margin 0.0%

Operating Margin (1034.7%)

Net Margin 0.0%

EBITDA Margin 0.0%

Growth & Returns

Revenue Growth (YoY)

23.5%

Return on Assets

(70.7%)

Liquidity & Leverage

Current Ratio

1.27

Quick Ratio

1.18

Total Cash

16.45M

Total Debt

23.25M

About

Acusphere, Inc. operates as a specialty pharmaceutical company that develops and commercializes cardiovascular drugs. It offers Imagify (perflubutane polymer microspheres), a cardiovascular drug that evaluates myocardial perfusion and detects coronary artery disease. It provides Imagify as an injectable suspension. The company was formerly known as Polymers For Medicine, Inc. and changed its name to Acusphere, Inc. in March 2004. Acusphere, Inc. was founded in 1993 and is based in Watertown, Massachusetts.